National spending on health care exceeds $3 trillion per year—almost 18% of GDP—and more than 60% of it was paid by government payors. This has led to a complex commercial, regulatory, and enforcement environment that is in a constant state of flux. Alston & Bird guides you to your goals with a trusted and responsive legal and policy team that can cover every area of your health care business.
A fast-moving and increasingly complex regulatory environment, shifting demographics, and other changes affect your business. As a business leader, you seek opportunities to expand products and services, offer new solutions in the marketplace, and remain competitive. Staying competitive requires sound judgment, knowledge, and agility. Hospitals and health care systems, ancillary care providers, payors, and device and drug manufacturers face challenges that call for responsive counsel who live and breathe the health care industry.
With one of the largest health law practices in the U.S., Alston & Bird offers creative solutions to your legal and business challenges with a cost-efficient approach. With nearly 100 professionals, including lawyers and policy advisors, our team is one of the largest of its kind in the U.S. Our team is fully focused on health care and life sciences, allowing us to quickly spot impending trends, developing rules and regulations, and new technologies that could affect your strategy.
Our team includes a full range of lawyers—regulatory specialists, policy advisors, transactional counsel, and litigators—who are focused entirely on health care. Our transactional team represents health care industry participants across the country in a wide variety of corporate and financial transactions. Their extensive experience in the unique health care commercial and regulatory environment allows them to add value beyond that of typical corporate counsel. Our health care litigators include seasoned veterans who served in the DOJ. In addition, our team includes one of the largest health policy practices in the country with former Administration and congressional officials and staffers lending an inside perspective on the Hill and Executive Branch as well as FDA regulatory issues, investigations, and policy matters.
Health Care Sectors
We represent clients across many different health care industries and disciplines, from start-ups to Fortune 500 companies. Our clients include:
Ancillary care providers
Diagnostics and imaging providers
Financial institutions and specialty lenders
Health plans and managed care plans
Hospitals and health systems, both not-for-profit and for profit
Industry trade associations
Manufacturers and distributers of pharmaceuticals and medical devices
Large physician groups
Post-acute care providers (including home health, hospice, rehab, skilled nursing)
Five Alston & Bird Attorneys Recognized with JD Supra 2021 “Readers’ Choice Awards”
Five Alston & Bird attorneys have been recognized by JD Supra with its 2021 “Readers’ Choice Awards” as top authors for their insights and commentary.
Press ReleaseApril 1, 2021
Alston & Bird Launches Health Care Digital Transformation Service
Alston & Bird has introduced a new service offering to assist health care and technology companies in navigating the ever-changing health IT regulatory and policy landscape.
Press ReleaseMarch 10, 2021
Alston & Bird Expands Bipartisan Health Care Policy and Regulatory Practice in Washington, D.C.
Alston & Bird has expanded its health care policy and regulatory capabilities with the addition of James “JP” Paluskiewicz, former Republican chief health counsel for the House Committee on Energy and Commerce’s Subcommittee on Health, and a strategic alliance with Neleen Rubin, a past Democratic member of the Senate Finance Committee health policy team. Both will be key senior policy additions to the firm’s Washington, D.C. office.
Press ReleaseMarch 9, 2021
Cathy Burgess Honored as a 2021 “Health Care | Life Science Trailblazer” by The National Law Journal
Cathy Burgess, partner in Alston & Bird’s Health Care Group and leader of the firm’s FDA Compliance & Enforcement Team, has been recognized by The National Law Journal in its third annual list of professionals identified as agents of change in health care and life sciences law.